In Recognition of Lung Cancer Awareness Month

Best Practices in Lung Cancer – November 2017 Vol 8 —November 15, 2017
Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+; University Distinguished Service Professor of Breast Cancer, Administrative Director, The Johns Hopkins Breast Center; Director, Johns Hopkins Cancer Survivorship Programs; Professor of Surgery and Oncology, JHU School of Medicine; Co-Creator, Work Stride-Managing Cancer at Work
shockli@jhmi.edu

Dear Navigators,

The principles of navigation began in the discipline of breast cancer. After observing the tremendous success of removing barriers to care as an effective method to improve clinical outcome and patient satisfaction, navigation tactics have been incorporated into many oncology disciplines. In this Special Edition, we direct our attention to lung cancer and the positive impact navigators have had in this disease state.

Lung cancer is a field in which great strides have been made over the past decade. From smoking cessation programs to the introduction of immunotherapy to the development and implementation of lung nodule screening, patients living with lung cancer have more treatment options and lifestyle-enhancing services available to them than ever before.

In this issue, we present an interview with Wendy Brooks, RN, ONN-CG(T), a thoracic nurse navigator at the HCA Midwest Research Medical Center, about her typical, or not so typical, day as a navigator. We are pleased to present an article by Amy M. Norton, RN, MSN, ONN-CG(T), and colleagues entitled “Lung Cancer. Now What? Plans and How We ‘Navigate’ Them.” We also bring you news in lung cancer from the European Society for Medical Oncology 2017 Congress.

It is our hope that this issue is a valuable resource to the nurse and patient navigators who work tirelessly to help their patients living with lung cancer. Thank you for all you do for your patients and for your valued and loyal readership.

Sincerely,

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+

University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles
Lorbrena (Lorlatinib) Approved for the Treatment of Metastatic Non–Small-Cell Lung Cancer with ALK Mutation
Loretta Fala
|
2019 Fourth Annual Oncology Guide to New FDA Approvals
Lung and bronchus cancer, the second most common form of cancer, accounts for 13.5% of all new cancer cases in the United States. In 2018 alone, lung cancer was newly diagnosed in 234,030 individuals and accounted for 154,050 deaths. In fact, lung cancer is the leading cause of cancer-related mortality in men and women, and is responsible for more than 25% of all cancer deaths. The 5-year survival rate for patients whose lung cancer has spread regionally (to regional lymph nodes) is 29.7%, but that survival rate is only 4.7% for patients with distant metastases.
Vizimpro (Dacomitinib) Approved for First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer with EGFR Mutation
Loretta Fala
|
2019 Fourth Annual Oncology Guide to New FDA Approvals
Lung and bronchus cancer is the second most common form of cancer in the United States. In 2018, lung cancer was newly diagnosed in 234,030 individuals, representing 13.5% of all new cancer cases. Lung cancer remains the leading cause of cancer mortality in men and women, accounting for more than 25% of all cancer deaths, which translated to 154,050 deaths in 2018. The relative 5-year survival rate for metastatic lung cancer is only 4.7%.
Setting Goals and Celebrating the Accomplishments
Lillie D. Shockney, RN, BS, MAS, ONN-CG
|
June 2019 Vol 10, No 6
Last modified: June 9, 2018

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code